Advances in Mechanisms and Management Strategies of Pulmonary Hypertension: A Review
Reviews in Cardiovascular Medicine · 14.10.2026 · 27 (10)
DOI: 10.31083/rcm49075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 14.10.2026. Verfasst von Anqi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chinese Academy of Medical Sciences & Peking Union Medical College, 100730 Beijing, China. Die Arbeit nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding & Elite Medical Professionals Project of China-Japan Friendship Hospital.
Abstract (Originalsprache)
Pulmonary hypertension (PH) encompasses a heterogeneous group of disorders characterized by persistently elevated pulmonary artery pressure and driven by diverse etiologies and intersecting pathological mechanisms. In recent years, substantial advances have clarified key contributors to PH pathogenesis, including pulmonary vascular remodeling, immune–inflammatory dysregulation, and genetic predispositions. Concurrently, diagnostic and therapeutic approaches tailored to different PH subtypes have evolved, incorporating targeted pharmacological treatments, interventional procedures, and lung transplantation. This review summarizes recent advances in elucidating the mechanisms underlying PH and outlines clinical management strategies across the major etiologic categories. Particular emphasis is placed on developments in PH-specific therapies and on emerging therapeutic targets to provide a coherent mechanistic framework and practical guidance for clinicians involved in the diagnosis and treatment of this challenging disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chinese Academy of Medical Sciences & Peking Union Medical College, 100730 Beijing, China.
- Department of Radiology, China-Japan Friendship Hospital, 100029 Beijing, China.
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; National Center for Respiratory Medicine; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Re…
- State Key Laboratory of Respiratory Health and Multimorbidity, China-Japan Friendship Hospital, 100029 Beijing, China.
- Peking University Health Science Center, 100191 Beijing, China.
ORCID-Profile: Anqi Liu, Linfeng Xi, Jie Du, Yanlin Guo, Hanchi Yu, Shuai Zhang, Wanmu Xie, Min Liu
Förderung
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding & Elite Medical Professionals Project of China-Japan Friendship Hospital
Zitieren
APA
Liu, A., Xi, L., Du, J., Guo, Y., Yu, H., Zhang, S., Xie, W., & Liu, M. (2026). Advances in Mechanisms and Management Strategies of Pulmonary Hypertension: A Review. Reviews in Cardiovascular Medicine, 27(10). https://doi.org/10.31083/rcm49075
Vancouver
Liu A, Xi L, Du J, Guo Y, Yu H, Zhang S, et al. Advances in Mechanisms and Management Strategies of Pulmonary Hypertension: A Review. Reviews in Cardiovascular Medicine. 2026;27(10). doi:10.31083/rcm49075
BibTeX
@article{Liu2026,
author = {Liu, Anqi and Xi, Linfeng and Du, Jie and Guo, Yanlin and Yu, Hanchi and Zhang, Shuai and Xie, Wanmu and Liu, Min},
title = {Advances in Mechanisms and Management Strategies of Pulmonary Hypertension: A Review},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
volume = {27},
number = {10},
doi = {10.31083/rcm49075}
}
EUVIMED